Atea Pharmaceuticalsinc Stock Filter Stocks by Fundamentals
AVIR Stock | USD 4.04 0.04 1.00% |
Atea PharmaceuticalsInc fundamentals help investors to digest information that contributes to Atea PharmaceuticalsI's financial success or failures. It also enables traders to predict the movement of Atea Stock. The fundamental analysis module provides a way to measure Atea PharmaceuticalsI's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atea PharmaceuticalsI stock.
Atea | Number of Shares Shorted |
Atea Number of Shares Shorted Analysis
2021 | 2023 | 2024 (projected) | Fixed Asset Turnover | 15.3K | 13.7K | 14.4K | Current Ratio | 13.58 | 18.24 | 13.21 |
Atea Number of Shares Shorted Driver Correlations
Understanding the fundamental principles of building solid financial models for Atea PharmaceuticalsI is extremely important. It helps to project a fair market value of Atea Stock properly, considering its historical fundamentals such as Number of Shares Shorted. Since Atea PharmaceuticalsI's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Atea PharmaceuticalsI's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Atea PharmaceuticalsI's interrelated accounts and indicators.
Click cells to compare fundamentals
Competition |
Based on the recorded statements, Atea PharmaceuticalsInc has 0.0null of outstending shares currently sold short by investors. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Number of Shares Shorted (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Crypto Correlations Now
Crypto CorrelationsUse cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |
All Next | Launch Module |
Atea Fundamentals
Return On Equity | -0.23 | ||||
Return On Asset | -0.12 | ||||
Current Valuation | (239.05 M) | ||||
Shares Outstanding | 84.16 M | ||||
Shares Owned By Insiders | 9.46 % | ||||
Shares Owned By Institutions | 67.42 % | ||||
Number Of Shares Shorted | 1.7 M | ||||
Price To Earning | 15.03 X | ||||
Price To Book | 0.61 X | ||||
Price To Sales | 1.90 X | ||||
Gross Profit | (81.94 M) | ||||
EBITDA | (163.75 M) | ||||
Net Income | (135.96 M) | ||||
Cash And Equivalents | 684.48 M | ||||
Cash Per Share | 8.22 X | ||||
Total Debt | 2.4 M | ||||
Debt To Equity | 0.01 % | ||||
Current Ratio | 27.46 X | ||||
Book Value Per Share | 6.65 X | ||||
Cash Flow From Operations | (85.39 M) | ||||
Short Ratio | 4.62 X | ||||
Earnings Per Share | (1.63) X | ||||
Target Price | 3.5 | ||||
Number Of Employees | 75 | ||||
Beta | 0.17 | ||||
Market Capitalization | 339.6 M | ||||
Total Asset | 594.97 M | ||||
Retained Earnings | (195.84 M) | ||||
Working Capital | 558.08 M | ||||
Current Asset | 97.88 M | ||||
Current Liabilities | 6.25 M | ||||
Z Score | 84.59 | ||||
Net Asset | 594.97 M |
About Atea PharmaceuticalsI Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Atea PharmaceuticalsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atea PharmaceuticalsI using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atea PharmaceuticalsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. Atea Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 63 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atea PharmaceuticalsI in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atea PharmaceuticalsI's short interest history, or implied volatility extrapolated from Atea PharmaceuticalsI options trading.
Pair Trading with Atea PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atea PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atea PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving together with Atea Stock
0.74 | CLVRW | Clever Leaves Holdings | PairCorr |
Moving against Atea Stock
0.87 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.78 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.65 | MGTX | MeiraGTx Holdings PLC Financial Report 9th of May 2024 | PairCorr |
0.62 | MBRX | Moleculin Biotech Financial Report 9th of May 2024 | PairCorr |
0.59 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
The ability to find closely correlated positions to Atea PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atea PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atea PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atea PharmaceuticalsInc to buy it.
The correlation of Atea PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atea PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atea PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atea PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Atea PharmaceuticalsI Piotroski F Score and Atea PharmaceuticalsI Altman Z Score analysis. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Complementary Tools for Atea Stock analysis
When running Atea PharmaceuticalsI's price analysis, check to measure Atea PharmaceuticalsI's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atea PharmaceuticalsI is operating at the current time. Most of Atea PharmaceuticalsI's value examination focuses on studying past and present price action to predict the probability of Atea PharmaceuticalsI's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atea PharmaceuticalsI's price. Additionally, you may evaluate how the addition of Atea PharmaceuticalsI to your portfolios can decrease your overall portfolio volatility.
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |
Is Atea PharmaceuticalsI's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atea PharmaceuticalsI. If investors know Atea will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atea PharmaceuticalsI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 2.641 | Earnings Share (1.63) | Revenue Per Share 2.31 | Quarterly Revenue Growth 2.952 | Return On Assets (0.12) |
The market value of Atea PharmaceuticalsInc is measured differently than its book value, which is the value of Atea that is recorded on the company's balance sheet. Investors also form their own opinion of Atea PharmaceuticalsI's value that differs from its market value or its book value, called intrinsic value, which is Atea PharmaceuticalsI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atea PharmaceuticalsI's market value can be influenced by many factors that don't directly affect Atea PharmaceuticalsI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atea PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if Atea PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atea PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.